Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1730181000168112 | cobicistat + elvitegravir + emtricitabine + tenofovir alafenamide (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1730191000168110 | tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | Is a | cobicistat | true | Inferred relationship | Some | ||
| tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | elvitegravir | true | Inferred relationship | Some | 3 | |
| tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | cobicistat | true | Inferred relationship | Some | 2 | |
| tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 1 | |
| tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | has intended active ingredient | tenofovir alafenamide | true | Inferred relationship | Some | 4 | |
| tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | Is a | emtricitabine + tenofovir alafenamide | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | Is a | True | tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR